跳至主要内容
临床试验/NCT01450631
NCT01450631已完成不适用

A Prospective, Randomized, Evaluation of the Prevena™ Incision Management System on Closed Incisions in Obese Subjects Undergoing Cesarean Section Surgery

KCI USA, Inc2 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2012年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
KCI USA, Inc
入组人数
92
试验地点
2
主要终点
Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.

研究概览

简要总结

The purpose of this study is to compare the post-surgical standard-of-care dressing to the Prevena™ Incision Management System in women undergoing Cesarean section surgery.

详细描述

This is a randomized, open-label, single-center, Phase IV, comparative interventional study looking at the effect of the Prevena™ Incision Management System (PIMS) on Cesarean section Subjects compared to a control arm treated with a standard-of-care surgical incision dressing. The prospective, post-marketing clinical study described in this protocol will assess the effectiveness and functional performance of PIMS on closed incisions. Clinical outcomes of interest for this study are defined as Surgical Site Occurrences (SSOs) that include unanticipated local inflammatory response, prolonged drainage, fluid collection, dehiscence, and surgical site infection (SSI). This investigation will compare these outcomes to a control group consisting of Subjects screened for the same inclusion and exclusion criteria but treated with a standard-of-care surgical incision dressing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The Subject:
  • is a female aged ≥ 18 years
  • is able to provide her own informed consent
  • will undergo a Cesarean section procedure using a subcuticular skin closure technique within the next 42 days
  • will require a surgical incision able to be covered completely by the PIMS skin interface
  • has a BMI ≥ 35 kg/m2 as determined during the Screening Period up to 42 days pre-surgery
  • is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
  • Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered
  • Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination
  • is willing and able to return for all scheduled and required study visits
  • is not concurrently enrolled in another clinical intervention trial which may impact maternal health or the surgical site

排除标准

  • The Subject:
  • is ASA Class P4, P5, or P6 (Appendix F - American Society of Anesthesiologists (ASA) Physical Status Classification System)
  • has a systemic bacterial or fungal infection at the time of surgery
  • has a remote-site skin infection at the time of surgery
  • has a life expectancy of < 12 months
  • is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:
  • Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
  • Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
  • experiences intraoperative hemorrhage requiring transfusion, disseminated-intravascular coagulopathy (DIC) or other medical or surgical condition during the Cesarean section deemed by the investigator to pose a prohibitively high risk for surgical re-exploration
  • who, in the investigator's opinion, would have any clinically significant condition that would impair the participant's ability to comply with the study procedures
  • has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives

结局指标

主要结局

Incidence of Postoperative Surgical Site Occurrences (SSOs) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.

时间窗: Post-op Day 42 (+/- 10 days) after Cesarean section surgery

Incidence of postoperative surgical site occurrences (SSOs) post Cesarean section surgery. SSOs include: * Unanticipated local inflammatory response * Prolonged drainage * Fluid collection * Dehiscence * Surgical site infection (SSI)

次要结局

  • Incidence Rate of Surgical Incision Intervention (SII) up to Day 42 (+/- 10 Days) Post Cesarean Section Surgery.(Post-op Day: 42 (+/- 10 days) after Cesarean section surgery)

研究者

发起方
KCI USA, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

The Use of the Prevena™ Incision Management System... | 临床试验